Phoay Luan Lee, PA
Physician Assistant · Norman, OKNPI 1154866747
Payments from drug & device makers
Across 111 payments — averaging $14.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vanda Pharmaceuticals Inc.$276
- AbbVie$260
- Sunovion Pharmaceuticals Inc.$254
- Alkermes, Inc.$179
- Johnson & Johnson$178
- Teva Pharmaceuticals USA, Inc.$120
- plus $382 from 6 others
What the payments were for
- Food & beverage$1,57696%
- Education$724%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 16 | $276 |
| AbbVie | 14 | $260 |
| Sunovion Pharmaceuticals Inc. | 26 | $254 |
| Alkermes, Inc. | 9 | $179 |
| Johnson & Johnson | 14 | $178 |
| Teva Pharmaceuticals USA, Inc. | 11 | $120 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $96 |
| Otsuka America Pharmaceutical, Inc. | 5 | $84 |
| Sanofi-aventis U.S. LLC | 1 | $72 |
| Neurocrine Biosciences, Inc. | 4 | $56 |
| Indivior Inc. | 3 | $54 |
| Sanofi | 1 | $20 |
How this compares
$1,648 in reported general payments places this provider in the 75th percentile of 1,491 physician assistant providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Chlorpromazine Hcl | 17 | $3,533 |
| Olanzapine | 17 | $1,180 |
| Duloxetine Hcl | 26 | $1,174 |
| Quetiapine Fumarate | 57 | $997 |
| Divalproex Sodium ErDivalproex Sodium | 35 | $976 |
| Buspirone Hcl | 60 | $969 |
| Bupropion XlBupropion Hcl | 42 | $947 |
| Aripiprazole | 22 | $878 |
| Gabapentin | 51 | $827 |
| Haloperidol Decanoate | 11 | $786 |
| Risperidone | 39 | $647 |
| Lamotrigine | 31 | $501 |
| Sertraline Hcl | 53 | $472 |
| Hydroxyzine Hcl | 14 | $468 |
| Hydroxyzine Pamoate | 26 | $399 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Norman
- Stephanie PorterNorman$11K
- Eric CampbellEdmond$246K
- Katherine DemersEl Reno$146K
- Jennifer SmithOklahoma City$134K
- Christy NiehuesMustang$28K
- Matthew PattonTulsa$24K
- Sarah HawkOklahoma City$23K
- Gavin ChristieEdmond$19K
- Michelle GreenTulsa$18K
- Muge ParkTulsa$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.